Supernus Announces Merger with Indivior
Supernus and Indivior are merging to form a diversified CNS biopharmaceutical leader. The transaction is dependent on stockholder and regulatory approvals.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day